| Name | Title | Contact Details |
|---|
One of the Worlds Largest Golf Simulator Companies, founded in South Korea in 2000. Winner of five consecutive Golf Digest Awards for Best Golf Simulator (2017-2021). We have over 9,449 sites worldwide, in 41 countries, with 47,500 simulators in operation. Over 99 million rounds are played annually.
American National Bank & Trust is a financial institution with a history dating back to 1856. Originally established as West Omaha National Bank, it has grown to be one of the largest banks in the Midwest, serving clients in Nebraska, Iowa, and Minnesota. The bank focuses on personalized service and building long-term relationships with both business and personal clients. The bank offers a wide range of financial services, including checking and savings accounts, consumer lending, mortgage lending, and construction financing. It also provides trust and investment services, managing approximately $1 billion in assets, and offers real estate title services, equipment and auto leasing, and personal investment services. American National Bank & Trust is committed to fiscal responsibility and conservative banking practices, ensuring financial strength and stability for its customers.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
LFI specializes in the sale and service of contemporary furnishings to public, private, school, and academic libraries. By meeting the rapidly changing sociological and technological changes through design and product, LFI has become the Midwests leading library furnishing company.
USXA is a full-service accounting firm offering tax, audit and assurance, business valuation, outsourced CFO, and more.